Cargando…

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors

BACKGROUND: Mucinous ovarian tumors are an unusual group of rare neoplasms with an apparently clear progression from benign to borderline to carcinoma, yet with a controversial cell of origin in the ovarian surface epithelium. They are thought to be molecularly distinct from other ovarian tumors but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryland, Georgina L., Hunter, Sally M., Doyle, Maria A., Caramia, Franco, Li, Jason, Rowley, Simone M., Christie, Michael, Allan, Prue E., Stephens, Andrew N., Bowtell, David D L, Campbell, Ian G., Gorringe, Kylie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528310/ https://www.ncbi.nlm.nih.gov/pubmed/26257827 http://dx.doi.org/10.1186/s13073-015-0210-y

Ejemplares similares

Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2017)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
por: Youssef, Arkan, et al.
Publicado: (2021)

Therapeutic options for mucinous ovarian carcinoma☆
por: Gorringe, Kylie L., et al.
Publicado: (2020)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
por: Kader, Tanjina, et al.
Publicado: (2018)

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
por: Lung, Mei Sim, et al.
Publicado: (2020)

Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer
por: Davis, Sally J, et al.
Publicado: (2011)

MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers
por: Ryland, Georgina L., et al.
Publicado: (2012)

Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials
por: Nugawela, Devindee, et al.
Publicado: (2023)

A simple consensus approach improves somatic mutation prediction accuracy
por: Goode, David L, et al.
Publicado: (2013)

The molecular origin and taxonomy of mucinous ovarian carcinoma
por: Cheasley, Dane, et al.
Publicado: (2019)

Mucinous Non-neoplastic Cyst of the Pancreas
por: Yang, Jae Do, et al.
Publicado: (2013)

Inferring copy number and genotype in tumour exome data
por: Amarasinghe, Kaushalya C, et al.
Publicado: (2014)

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
por: Etemadmoghadam, Dariush, et al.
Publicado: (2010)

CONTRA: copy number analysis for targeted resequencing
por: Li, Jason, et al.
Publicado: (2012)

Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast
por: Pang, Jia-Min B., et al.
Publicado: (2015)

Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?
por: Molaei, Mahsa, et al.
Publicado: (2010)

Mucinous non neoplastic cyst of the pancreas: a case report
por: Elahabadi, Ismail, et al.
Publicado: (2023)

Profiling the immune landscape in mucinous ovarian carcinoma
por: Meagher, Nicola S., et al.
Publicado: (2023)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

A retrospective analysis and literature review of neoplastic appendiceal mucinous lesions
por: Matias-García, Belén, et al.
Publicado: (2021)

Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment
por: Li, Jason, et al.
Publicado: (2014)

When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
por: Salazar, Carolina, et al.
Publicado: (2018)

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
por: Gorringe, Kylie L., et al.
Publicado: (2010)

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

The genomic landscape of carcinomas with mucinous differentiation
por: Nguyen, Bastien, et al.
Publicado: (2021)

Intraductal papillary mucinous neoplasm of the biliary tract: A precursor lesion to cholangiocarcinoma
por: Ritchie, David J., et al.
Publicado: (2019)

Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium
por: Babu, Subramani Durai, et al.
Publicado: (2006)

Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions
por: Businello, Gianluca, et al.
Publicado: (2021)

The uptake of 5-hydroxytryptamine, histamine, and their amino acid precursors by neoplastic mast cells.
por: Green, J. P.
Publicado: (1966)

Proteomic Mucin Profiling for the Identification of Cystic Precursors of Pancreatic Cancer
por: Jabbar, Karolina S., et al.
Publicado: (2014)

Duodenal Carcinoma with Neoplastic Transformation of the Underlying Brunner's Glands
por: Christie, A. C.
Publicado: (1953)

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017)

Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin
por: Alakus, Hakan, et al.
Publicado: (2014)

Incidentally discovered low‐grade appendiceal mucinous neoplasm: a precursor to pseudomyxoma peritonei
por: Padmanaban, Vennila, et al.
Publicado: (2016)

An RNA seq-based reference landscape of human normal and neoplastic brain
por: Arora, Sonali, et al.
Publicado: (2023)

An RNA seq-based reference landscape of human normal and neoplastic brain
por: Arora, Sonali, et al.
Publicado: (2023)

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oh39djiqh4teaj372msdrub1lt